Filing Details

Accession Number:
0001127602-14-023383
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-16 17:37:23
Reporting Period:
2014-07-16
Filing Date:
2014-07-16
Accepted Time:
2014-07-16 17:37:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235598 M James Frates Connaught House
1 Burlington Road
Dublin 4 Ireland
Svp & Cfo, Alkermes Plc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-07-16 8,000 $8.55 52,225 No 4 M Direct
Ordinary Shares Disposition 2014-07-16 8,000 $46.50 44,225 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2014-07-16 8,000 $0.00 8,000 $8.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
57,000 2019-05-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 4,000 Indirect By Sons
Ordinary Shares 57,000 Indirect By GRAT
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.02 to $46.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. Shares held by James M. Frates Grantor Retained Annuity Trust dated March 14, 2014 (the "GRAT"). The Reporting Person is a trustee and beneficiary of the GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the GRAT.
  5. These options are fully vested in accordance with their terms.